Recruiting PHASE1/PHASE2 INTERVENTIONAL 2-arm
NCT07183384
MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction (EXITPE)
The Effectiveness of Mesenchymal Stem Cell-Derived Exosome Therapy in Improving Endothelial Dysfunction in Postpartum Mothers With a History of Preeclampsia
Sponsor: Dr Cipto Mangunkusumo General Hospital
Updated 1 time since 2025 Last updated: Sep 12, 2025 Started: Jul 1, 2024 Primary completion: Jul 1, 2026 Completion: Sep 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1/PHASE2 clinical study on Cell Therapy and Endothelial Injury, this trial is actively recruiting participants. The trial is conducted by Dr Cipto Mangunkusumo General Hospital and has accumulated 1 data snapshot since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Recruiting — PHASE1/PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Dr Cipto Mangunkusumo General Hospital
- Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
- Dr. Sardjito Hospital, Yogyakarta
- Universitas Padjadjaran
Data source: Universitas Padjadjaran
For direct contact, visit the study record on ClinicalTrials.gov .